Year-End Sale is Live! Find Exclusive Prices on the Best Selling Pharma & MedTech Reports. Check Now!

neurodegenerative diseases

Oct 23, 2024

Plasma Proteins Therapeutics: Transforming Treatment in Hematology and Beyond

Oct 21, 2024

Exosomes: Tiny Messengers with Big Potential in Medical Science

Dec 19, 2023

Eisai Submits Marketing Authorization Application for Tasurgratinib; CHMP Issues Positive Opinion for Biogen’s SKYCLARYS; European Commission Approves Merck’s KEYTRUDA + Chemotherapy HER2-ve Gastric or GEJ Adenocarcinoma; BMS Provides Update on RELATIVITY-123 Trial; Kyverna Therapeutics Granted FDA Fast Track Designation for KYV-101; Verrica and Torii Pharma Announces Positive Top-line Results from a Confirmatory Phase 3 Trial of TO-208

Dec 26, 2018

‘Transmissible’ Alzheimer’s theory gains traction

Newsletter/Whitepaper